Your browser doesn't support javascript.
loading
Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control study.
Muñoz-Montaño, Wendy R; Cabrera-Galeana, Paula; De la Garza-Ramos, Cynthia; Azim, Hatem A; Tabares, Ariana; Perez, Victor; Porras Reyes, Fanny; Sanchez Benitez, Daniel; Alvarado-Miranda, Alberto; Lara-Medina, Fernando; Vazquez Romo, Rafael; Bargallo-Rocha, Enrique; Arrieta, Oscar; Villarreal-Garza, Cynthia.
Afiliação
  • Muñoz-Montaño WR; Breast Medical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Cabrera-Galeana P; Breast Medical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • De la Garza-Ramos C; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, Av. Batallon de San Patricio 112, 66278, Real San Agustin, San Pedro Garza Garcia, NL, Mexico.
  • Azim HA; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, Av. Batallon de San Patricio 112, 66278, Real San Agustin, San Pedro Garza Garcia, NL, Mexico.
  • Tabares A; Breast Medical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Perez V; Oncological Pathology of Mammary Tumors Unit, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Porras Reyes F; Oncological Pathology of Mammary Tumors Unit, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Sanchez Benitez D; Medical School, National Autonomous University of Mexico, Mexico City, Mexico.
  • Alvarado-Miranda A; Breast Medical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Lara-Medina F; Breast Medical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Vazquez Romo R; Breast Surgical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Bargallo-Rocha E; Breast Surgical Oncology, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico.
  • Arrieta O; Research Unit, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico. ogar@unam.mx.
  • Villarreal-Garza C; Head of Thoracic Oncology Unit and Laboratory of Personalized Medicine, National Institute of Cancer, San Fernando #22, Section XVI, 14080, Tlalpan, Mexico City, Mexico. ogar@unam.mx.
Breast Cancer Res Treat ; 188(2): 489-500, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34132938

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Neoplásicas na Gravidez / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Neoplásicas na Gravidez / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: Holanda